Capex / revenue moved 16177 bp higher
Capex / revenue changed +16177 basis points from the comparable as-filed period.
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Capex / revenue changed +16177 basis points from the comparable as-filed period.
Capital expenditure changed +694.1% from the comparable as-filed period.
Cash & equivalents changed +64.1% from the comparable as-filed period.
Inventory changed +35.4% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
Net income changed +34.3% from the comparable as-filed period.
Operating income changed +27.0% from the comparable as-filed period.
Operating margin changed +4694 basis points from the comparable as-filed period.
Revenue changed +89.0% from the comparable as-filed period.
Selling, general & administrative changed +28.2% from the comparable as-filed period.
Stock-based compensation changed +103.3% from the comparable as-filed period.
Debt changed +2.6% from the comparable as-filed period.
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.